The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

A••••••••• I••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor not established · possible relationship
Also written as: Inc. and
Principal held
at least $17.5M
sum of BDC pieces, a lower bound
Fair value
$17.6M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Jun 1, 2029
no dated debt inside 24 months
On the tape since
Jun 30, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $17.5M100cS+245 bpJun 1, 20291
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••term loan first lien
S••••• S••••••, J••• 2029, P•••• + 2.45%, F•••• rate 9.70%, 6.25% E••• Fee
$17.5M$17.6M
100c
S+245 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$17.5M$17.6M100c0
Mar 31, 20261$17.5M$17.4M99c0
Dec 31, 20251$35.0M$34.8M100c0
Sep 30, 20251$7.5M$7.5M100c0
Jun 30, 20251$7.5M$7.4M100c0
What changed
Every change including routine ones
Identity
Group key
ALTIMMUNEderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it